644:
define sites of vulnerability on HIV envelope protein. These antibodies include isolation of broad and potent antibodies 10E8, 35O22, and N6, among others a potent antibody which can neutralize nearly all HIV strains.This discovery has broad implications for the development of HIV treatments and vaccines, as it targets a crucial part of the virus that attaches to immune cells, making it a promising candidate for therapeutic use.
517:
491:
470:
457:
393:
329:
838:
635:, and infectious diseases training at NIAID and the Children's Hospital of Philadelphia. He has been with the NIH since 1989, initially studying the immune response to respiratory viruses before shifting his focus to HIV in 1994. His career highlights include pioneering studies on the immunologic control of HIV, particularly in
498:
this draft is accepted, a hatnote will need to be added to the primary page to refer to this page. If there is already a hatnote on the primary page, please review whether a disambiguation page is in order instead. Please do not edit the primary page unless you are accepting this draft.The primary page is
497:
The title of this draft either has been disambiguated or will require disambiguation if accepted.If this draft has been disambiguated (renamed), submitters and reviewers are asked to consider whether the current title is the best possible disambiguation, and, if necessary, move (rename) this draft.If
643:
In addition to his work on the cellular immune response to HIV, he has made numerous contributions to our understanding of the antibody response. These include identifying patients with broad antibody responses to HIV, and from these patients isolating broad and potent monoclonal antibodies that
647:
Dr. Connors' work has not only contributed to our understanding of HIV but also has implications for broader immunological research and public health. His publications and contributions to the scientific community are recognized and continue to influence the field of HIV research.
639:
or "elite controllers" who can control HIV without antiretroviral therapy. The study of this group of patients has provided insights for our understanding of an effective immune response to HIV and provided insights into potential strategies for HIV treatment and prevention.
619:(NIAID), where he oversees efforts to understand and enhance the immune response to HIV and other viruses. His research focuses on identifying effective immune responses to viruses, which are crucial for developing vaccines and immunotherapies.
226:
tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the
616:
876:
861:
866:
881:
71:
756:
871:
264:
160:
184:
59:
242:
63:
435:
371:
172:
48:
846:
676:
608:
178:
128:
95:
205:
132:
from experienced editors. These venues are only for help with editing and the submission process, not to get reviews.
416:
67:
278:
507:
575:
439:
375:
52:
636:
537:
431:
367:
352:
209:
190:
82:
If you have not resolved the issues listed above, your draft will be declined again and potentially deleted.
44:
79:
If you would like to continue working on the submission, click on the "Edit" tab at the top of the window.
268:
223:
144:
787:
704:
632:
503:
532:
693:"Broad and potent HIV-1 neutralization by a human antibody that binds the gp41āgp120 interface"
821:
803:
738:
720:
628:
563:
296:
691:
Huang, Jinghe; Kang, Byong H.; Pancera, Marie; Lee, Jeong Hyun; et al. (November 2014).
811:
795:
728:
712:
29:
842:
140:
70:. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid
212:
to find examples of
Knowledge's best writing on topics similar to your proposed article.
791:
708:
816:
775:
733:
692:
102:
Please do not remove reviewer comments or this notice until the submission is accepted.
855:
668:
524:
166:
147:. Some WikiProjects are more active than others so a speedy reply is not guaranteed.
499:
423:
359:
197:
194:
36:
774:
Huang, Jinghe; Ofek, Gilad; Laub, Leo; Louder, Mark K.; et al. (2012-11-15).
757:"NIH Scientists Identify Potent Antibody that Neutralizes Nearly All HIV Strains"
528:
481:
477:
456:
392:
328:
319:
Please note that if the issues are not fixed, the draft will be declined again.
139:, or if the review is taking a lot of time, you can try asking for help on the
592:
807:
724:
776:"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody"
825:
742:
447:
411:
612:
799:
716:
383:
347:
222:
To improve your odds of a faster review, tag your draft with relevant
615:. He serves as the Chief of the HIV-Specific Immunity Section at the
671:
402:
338:
15:
480:
wording. Only primary sources are cited at time of review. ~
455:
391:
327:
288:
24:
311:
300:
120:
87:
617:
National
Institute of Allergy and Infectious Diseases
588:
570:
559:
552:
60:
the formal tone expected of an encyclopedia article
58:This submission does not appear to be written in
434:. If you need help with referencing, please see
430:sources are required so that information can be
370:. If you need help with referencing, please see
366:sources are required so that information can be
47:. If you need help with referencing, please see
43:sources are required so that information can be
422:This submission is not adequately supported by
358:This submission is not adequately supported by
35:This submission is not adequately supported by
22:Submission declined on 10 June 2024 by
476:Needs to be significantly rewritten to remove
409:Submission declined on 16 May 2024 by
345:Submission declined on 16 May 2024 by
627:Dr. Connors received his medical degree from
8:
163:ā a basic overview on how to edit Knowledge.
549:
815:
732:
68:independent, reliable, published sources
657:
218:Improving your odds of a speedy review
877:Draft articles on medicine and health
7:
862:AfC submissions by date/09 June 2024
663:
661:
631:, followed by pediatric training at
867:AfC submissions by date/16 May 2024
161:Knowledge:Contributing to Knowledge
62:. Entries should be written from a
845:from websites or documents of the
193:ā make sure your article includes
14:
882:AfC submissions on living persons
185:Knowledge:Writing better articles
66:, and should refer to a range of
841: This article incorporates
836:
525:independent and reliable sources
515:
489:
468:
116:editing or submitting your draft
85:If you need extra help, please
173:Help:Referencing for beginners
1:
872:Draft articles on biographies
847:National Institutes of Health
677:National Institutes of Health
609:National Institutes of Health
187:ā how to improve your article
181:ā how to develop your article
179:Knowledge:Article development
126:at the AfC Help Desk or get
93:at the AfC Help Desk or get
206:Knowledge:Featured articles
175:ā how to include references
898:
527:are needed to demonstrate
510:) 19:20, 9 June 2024 (UTC)
598:
581:
547:HIV researcher at the NIH
523:Additional references in
484:21:31, 10 June 2024 (UTC)
436:Referencing for beginners
372:Referencing for beginners
99:from experienced editors.
74:that promote the subject.
49:Referencing for beginners
576:Long-term nonprogressors
542:13:22, 16 May 2024 (UTC)
299:3 months ago. Reviewer:
637:Long-term nonprogressor
607:is a researcher at the
210:Knowledge:Good articles
191:Knowledge:Verifiability
169:ā how to use the markup
843:public domain material
611:(NIH) specializing in
460:
396:
332:
245:Add tags to your draft
154:How to improve a draft
137:feedback on your draft
459:
395:
331:
64:neutral point of view
669:"Mark Connors, M.D."
633:Tufts Medical Center
204:You can also browse
145:relevant WikiProject
800:10.1038/nature11544
792:2012Natur.491..406H
763:. 18 November 2016.
717:10.1038/nature13601
709:2014Natur.515..138H
623:Career and Research
198:third-party sources
461:
451: 4 months ago.
397:
387: 4 months ago.
333:
292: 3 months ago.
786:(7424): 406ā412.
759:. Clinical Info.
703:(7525): 138ā142.
629:Temple University
602:
601:
583:Scientific career
564:Temple University
465:
464:
452:
445: Declined by
401:
400:
388:
381: Declined by
337:
336:
323:
322:
304:
293:
286: Declined by
122:ask us a question
114:If you need help
109:Where to get help
89:ask us a question
889:
840:
839:
830:
829:
819:
771:
765:
764:
753:
747:
746:
736:
688:
682:
681:
665:
550:
522:
519:
518:
496:
493:
492:
475:
472:
471:
450:
448:Umakant Bhalerao
444:
424:reliable sources
420:
414:
412:Umakant Bhalerao
403:
386:
380:
360:reliable sources
356:
350:
339:
316:
314:
307:
306:
294:
291:
285:
255:Editor resources
249:
247:
236:Women scientists
125:
92:
37:reliable sources
33:
27:
16:
897:
896:
892:
891:
890:
888:
887:
886:
852:
851:
850:
837:
834:
833:
773:
772:
768:
755:
754:
750:
690:
689:
685:
680:. 12 July 2022.
667:
666:
659:
654:
625:
560:Alma mater
555:
548:
545:
520:
516:
504:Robert McClenon
494:
490:
473:
469:
446:
443:
410:
408:
382:
379:
346:
344:
324:
312:
310:
295:Last edited by
287:
284:
283:
256:
252:
251:
250:
243:
241:
219:
215:
214:
202:
155:
151:
150:
119:
110:
106:
105:
86:
75:
56:
23:
21:
12:
11:
5:
895:
893:
885:
884:
879:
874:
869:
864:
854:
853:
835:
832:
831:
766:
748:
683:
656:
655:
653:
650:
624:
621:
600:
599:
596:
595:
590:
586:
585:
579:
578:
572:
571:Known for
568:
567:
561:
557:
556:
553:
546:
544:
543:
512:
511:
486:
485:
463:
462:
453:
440:Citing sources
421:
406:
399:
398:
389:
376:Citing sources
357:
342:
335:
334:
325:
321:
320:
317:
305:
282:
281:
257:
254:
253:
240:
220:
217:
216:
201:
200:
188:
182:
176:
170:
164:
157:
156:
153:
152:
149:
148:
133:
111:
108:
107:
104:
103:
100:
83:
80:
76:
57:
53:Citing sources
34:
19:
13:
10:
9:
6:
4:
3:
2:
894:
883:
880:
878:
875:
873:
870:
868:
865:
863:
860:
859:
857:
848:
844:
827:
823:
818:
813:
809:
805:
801:
797:
793:
789:
785:
781:
777:
770:
767:
762:
758:
752:
749:
744:
740:
735:
730:
726:
722:
718:
714:
710:
706:
702:
698:
694:
687:
684:
679:
678:
673:
670:
664:
662:
658:
651:
649:
645:
641:
638:
634:
630:
622:
620:
618:
614:
610:
606:
597:
594:
591:
587:
584:
580:
577:
573:
569:
565:
562:
558:
551:
541:
540:
536:
535:
530:
526:
514:
513:
509:
505:
501:
488:
487:
483:
479:
467:
466:
458:
454:
449:
441:
437:
433:
429:
425:
418:
413:
407:
405:
404:
394:
390:
385:
384:HitroMilanese
377:
373:
369:
365:
361:
354:
349:
348:HitroMilanese
343:
341:
340:
330:
326:
318:
315:
309:
308:
302:
301:Inform author
298:
290:
280:
279:Fix bare URLs
277:
274:
270:
266:
262:
259:
258:
248:
246:
239:
237:
233:
229:
225:
213:
211:
207:
199:
196:
192:
189:
186:
183:
180:
177:
174:
171:
168:
167:Help:Wikitext
165:
162:
159:
158:
146:
142:
138:
134:
131:
130:
124:
123:
117:
113:
112:
101:
98:
97:
91:
90:
84:
81:
78:
77:
73:
72:peacock terms
69:
65:
61:
54:
50:
46:
42:
38:
31:
26:
20:
18:
17:
783:
779:
769:
760:
751:
700:
696:
686:
675:
646:
642:
626:
605:Mark Connors
604:
603:
582:
574:Research on
554:Mark Connors
538:
533:
500:Mark Connors
427:
363:
297:Citation bot
275:
272:
265:Citation bot
260:
244:
235:
231:
227:
221:
203:
136:
135:If you need
127:
121:
115:
94:
88:
40:
478:MOS:PUFFERY
224:WikiProject
856:Categories
652:References
593:Immunology
529:notability
261:Easy tools
808:0028-0836
725:0028-0836
276:Advanced:
232:Astronomy
228:Biography
141:talk page
129:live help
118:, please
96:live help
826:23151583
743:25186731
613:HIV/AIDS
566:(BA, MD)
521:Comment:
495:Comment:
474:Comment:
432:verified
428:Reliable
368:verified
364:Reliable
313:Resubmit
195:reliable
45:verified
41:Reliable
817:4854285
788:Bibcode
761:HIV.gov
734:4224615
705:Bibcode
267: (
824:
814:
806:
780:Nature
741:
731:
723:
697:Nature
589:Fields
482:Liance
289:Liance
238:tags.
234:, and
25:Liance
672:NIAID
534:Hitro
143:of a
822:PMID
804:ISSN
739:PMID
721:ISSN
539:talk
508:talk
438:and
417:talk
374:and
353:talk
269:help
208:and
51:and
30:talk
812:PMC
796:doi
784:491
729:PMC
713:doi
701:515
858::
820:.
810:.
802:.
794:.
782:.
778:.
737:.
727:.
719:.
711:.
699:.
695:.
674:.
660:^
531:.
502:.
426:.
419:).
362:.
355:).
271:)
263::
230:,
39:.
32:).
849:.
828:.
798::
790::
745:.
715::
707::
506:(
442:.
415:(
378:.
351:(
303:.
273:|
55:.
28:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.